Coagulation factor VII and inflammatory markers in patients with coronary heart disease

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 5, 2007, Pages 473-477

  Ekström, Mattias ^a   Silveira, Angela ^a   Bennermo, Marie ^b   Eriksson, Per ^a   Tornvall, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

Arg353Gln polymorphism; Coronary heart disease; Factor VII; Inflammation; Myocardial infarction

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; FIBRINOGEN; GLUTAMINE; INTERLEUKIN 6;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ALLELES; AMINO ACID SUBSTITUTION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY DISEASE; FACTOR VIIA; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; QUANTITATIVE TRAIT LOCI;

EID: 34250858833     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3281a3057f     Document Type: Article

References (24)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-126.
2. Selwyn AP. Prothrombotic and antithrombotic pathways in acute coronary syndromes. Am J Cardiol 2003; 91:3H-11H.
3. Corti R, Hutter R, Badimon JJ, Fuster V. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J Thromb Thrombolysis 2004; 17:35-44.
4. Rao LV, Rapaport SI. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci U S A 1988; 85:6687-6691.
5. Spronk HM, van der Voort D, Ten Cate H. Blood coagulation and the risk of atherothrombosis: a complex relationship. Thromb J 2004; 2:12.
6. Cai Q, Chen J, Ma H, Song J, Xu M. Association of coagulation factor VII with the risk of myocardial infarction in the Chinese. Chin Med J (Engl) 2000; 113:1059-1063.
7. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2:533-537.
8. Moor E, Silveira A, van't Hooft F, Suontaka AM, Eriksson P, Blomback M, et al. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype. Arterioscler Thromb Vasc Biol 1995; 15:655-664.
9. Salomaa V, Rasi V, Kulathinal S, Vahtera E, Jauhiainen M, Ehnholm C, et al. Hemostatic factors as predictors of coronary events and total mortality: The FINRISK '92 Hemostasis Study. Arterioscler Thromb Vasc Biol 2002; 22:353-358.
10. Iacoviello L, Di Castelnuovo A, De Knijff P, D'Orazio A, Amore C, Arboretti R, et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998; 338:79-85.
11. Girelli D, Russo C, Ferraresi P, Olivieri O, Pinotti M, Friso S, et al. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000; 343:774-780.
12. Jeffery S, Poloniecki J, Leatham E, Bevan D, Ireson N, Talbot S, et al. A protective contribution of the Q allele of the R353Q polymorphism of the factor VII gene in individuals with chronic stable angina? Int J Cardiol 2005; 100:395-399.
13. Ogawa M, Abe S, Biro S, Saigo M, Kihara T, Setoyama S, et al. R353Q polymorphism, activated factor VII, and risk of premature myocardial infarction in Japanese men. Circ J 2004; 68:520-525.
14. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 1996; 16:72-76.
15. Hunault M, Arbini AA, Lopaciuk S, Carew JA, Bauer KA. The Arg353Gln polymorphism reduces the level of coagulation factor VII. In vivo and in vitro studies. Arterioscler Thromb Vasc Biol 1997; 17:2825-2829.
16. Bennermo M, Held C, Ericsson CG, Silveira A, Hamsten A, Tornvall P. Genotype-specific increase in plasma concentrations of activated coagulation factor VII in response to experimental inflammation. A link between infection and acute myocardial infarction? Thromb Haemost 2005; 94:427-431.
17. Porreca E, Di Febbo C, di Castelnuovo A, Baccante G, Amore C, Angelini A, et al. Association of factor VII levels with inflammatory parameters in hypercholesterolemic patients. Atherosclerosis 2002; 165:159-166.
18. Samnegard A, Silveira A, Lundman P, Boquist S, Odeberg J, Hulthe J, et al. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 - 1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 2005; 258:411-419.
19. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81:734-744.
20. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11:-546.
21. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351:2611-2618.
22. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343:915-922.
23. Wu AH, Tsongalis GJ. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol 2001; 87:1361-1366.
24. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006; 367:651-658.